Point-of-Care Testing Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Point-of-Care Testing. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Point-of-Care Testing Indian Medical PG Question 1: Which of the following attributes are essential for an ideal screening test?
- A. Safe
- B. Reliable
- C. Valid
- D. All of the options (Correct Answer)
Point-of-Care Testing Explanation: ***All of the options***
- An ideal screening test must possess **all three essential attributes**: safety, reliability, and validity.
- **Safe**: Minimizes harm to participants and ensures ethical implementation
- **Reliable**: Produces consistent, reproducible results with minimal random error
- **Valid**: Accurately measures what it intends to measure (high sensitivity and specificity)
- These three attributes work together as fundamental requirements for any effective screening program, ensuring that early detection benefits outweigh potential risks.
*Safe (alone)*
- While safety is absolutely essential, it is **not sufficient by itself** to make an ideal screening test.
- A test that is safe but unreliable or invalid would produce inconsistent or inaccurate results, rendering it ineffective for screening purposes.
*Reliable (alone)*
- Reliability ensures consistent results, which is crucial, but **reliability alone is insufficient**.
- A test can be highly reliable (consistently giving the same result) yet completely invalid if it measures the wrong thing or is unsafe.
*Valid (alone)*
- Validity is critical for accurate measurement, but **validity alone does not make a test ideal**.
- Even a valid test must be safe to protect participants and reliable to ensure consistency across different settings and times.
Point-of-Care Testing Indian Medical PG Question 2: Which of the following statements about screening for disease is false?
- A. Time consuming
- B. Arbitrary and final (Correct Answer)
- C. Rarely a basis for starting treatment without further confirmation
- D. Done on apparently healthy people
Point-of-Care Testing Explanation: ***Arbitrary and final*** ✓ **FALSE Statement - Correct Answer**
- Screening tests are **NOT arbitrary** - they use **established diagnostic criteria**, validated cutoff points, and standardized protocols
- Screening is **NOT final** - positive screening results always require **confirmatory diagnostic tests** before treatment decisions
- This statement is false because screening follows **evidence-based protocols** and serves as a **preliminary step** in disease detection, not a definitive diagnosis
*Time consuming* - TRUE Statement
- Mass screening programs are indeed **time-consuming** due to large population coverage, scheduling logistics, and follow-up requirements
- The process includes **participant recruitment**, **test administration**, **result notification**, and **tracking** of screen-positive individuals
*Rarely a basis for starting treatment without further confirmation* - TRUE Statement
- Screening tests are designed to **identify high-risk individuals** who require further evaluation, not to make treatment decisions
- **Confirmatory diagnostic tests** with higher specificity are required before initiating treatment
- Starting treatment based solely on screening results risks **overdiagnosis** and **unnecessary interventions** in false-positive cases
*Done on apparently healthy people* - TRUE Statement
- Screening specifically targets **asymptomatic populations** to detect disease in **preclinical stages**
- The goal is **early detection** before symptoms appear, when intervention may be most effective
- Distinguishes screening from diagnostic testing, which is performed on symptomatic individuals
Point-of-Care Testing Indian Medical PG Question 3: A frequent traveler presented with 4 days of continuous fever, abdominal pain, and bradycardia. What is the best diagnostic test to confirm the pathogen?
- A. Widal test
- B. Blood culture (Correct Answer)
- C. Urine culture
- D. Stool culture
Point-of-Care Testing Explanation: ***Blood culture***
- **Blood culture** is the most sensitive and specific test for confirming **typhoid fever** in the first week of illness.
- The presence of **continuous fever** (step-ladder pattern), **abdominal pain**, and **relative bradycardia** in a traveler strongly suggests typhoid fever caused by *Salmonella Typhi*.
*Widal test*
- The **Widal test** detects antibodies against *Salmonella Typhi* antigens and is often positive later in the disease course.
- It has **limited sensitivity and specificity**, especially in endemic areas or with prior vaccination, leading to false positives and negatives.
*Urine culture*
- **Urine culture** has a low yield for *Salmonella Typhi*, as bacteria are intermittently shed in urine, usually later in the disease.
- It's primarily useful for diagnosing **urinary tract infections** or in chronic carriers of typhoid.
*Stool culture*
- **Stool culture** yield is higher in the later stages of typhoid fever, as *Salmonella Typhi* is shed in feces.
- Its sensitivity is lower than blood culture in the early acute phase when bacteremia is most prominent.
Point-of-Care Testing Indian Medical PG Question 4: In a village health survey, which indicator best reflects the quality of antenatal care services?
- A. Number of ANC registrations
- B. Number of high-risk pregnancies identified
- C. Proportion of early ANC registrations (Correct Answer)
- D. Percentage of institutional deliveries
Point-of-Care Testing Explanation: ***Proportion of early ANC registrations***
- **Early antenatal care (ANC) registration** signifies that pregnant women are accessing care early in their pregnancy, allowing for timely interventions, screening, and health education that improve maternal and fetal outcomes.
- This indicator directly reflects the **accessibility and utilization** of quality ANC services from the beginning, which is crucial for comprehensive care.
*Number of ANC registrations*
- This simply indicates the **total uptake of ANC services**, but doesn't provide insight into the timeliness or quality of the care received.
- A high number of registrations could include many late registrations, which would limit the overall effectiveness of ANC.
*Number of high-risk pregnancies identified*
- While important for targeted interventions, this indicator primarily reflects the **screening capacity** of the health system, not the overall quality or comprehensiveness of routine ANC for all pregnancies.
- It doesn't capture whether these high-risk women are receiving adequate follow-up or whether low-risk women are receiving appropriate preventive care.
*Percentage of institutional deliveries*
- This indicator is an excellent measure of **safe delivery practices** and access to skilled birth attendance, but it reflects the quality of delivery services rather than the quality of antenatal care services themselves.
- A woman could have poor ANC but still deliver in an institution, thus it doesn't directly assess the care received *before* delivery.
Point-of-Care Testing Indian Medical PG Question 5: Which of the following statements accurately describes the relationship between quality assurance (QA), quality control (QC), internal quality assurance (IQA), and external quality assurance (EQA)?
- A. Quality Control (QC) is a process that supports Quality Assurance (QA).
- B. Quality Control (QC) and Quality Assurance (QA) are distinct but interrelated processes.
- C. Quality Assurance (QA) focuses solely on compliance and excludes Quality Control (QC).
- D. Quality Assurance (QA) includes Quality Control (QC), Internal Quality Assurance (IQA), and External Quality Assurance (EQA). (Correct Answer)
Point-of-Care Testing Explanation: ***Quality Assurance (QA) includes Quality Control (QC), Internal Quality Assurance (IQA), and External Quality Assurance (EQA).***
- **Quality Assurance (QA)** is the comprehensive, overarching system that encompasses all systematic activities designed to ensure quality throughout the entire process—from planning and design to implementation and evaluation.
- **Quality Control (QC)** is an integral component within QA that focuses on operational techniques and activities used to fulfill quality requirements and detect defects in the final product or service.
- **Internal Quality Assurance (IQA)** refers to quality assessment activities conducted within the organization itself (self-assessment, internal audits).
- **External Quality Assurance (EQA)** involves quality assessment by external agencies (proficiency testing, external audits, accreditation).
- All three (QC, IQA, EQA) function as **components within the broader QA framework**, making this the most comprehensive and accurate description of their relationship.
*Quality Control (QC) is a process that supports Quality Assurance (QA).*
- While this statement is true, it is incomplete and understates the relationship.
- QC is not merely "supportive" but is an **integral operational component** embedded within the QA system.
- This option fails to capture the comprehensive hierarchical relationship where QA serves as the umbrella framework encompassing QC, IQA, and EQA.
*Quality Control (QC) and Quality Assurance (QA) are distinct but interrelated processes.*
- From an operational perspective, QA (proactive, prevention-focused) and QC (reactive, detection-focused) do have distinct roles.
- However, in quality management frameworks, QC is best understood as a **functional component within the broader QA system** rather than as a separate parallel process.
- This option is less precise than the correct answer, which explicitly describes the inclusive hierarchical relationship.
*Quality Assurance (QA) focuses solely on compliance and excludes Quality Control (QC).*
- This statement is factually incorrect on both counts.
- **QA is not limited to compliance**; it encompasses proactive planning, continuous improvement, systematic monitoring, and excellence in all processes—far beyond mere regulatory compliance.
- **QA explicitly includes QC** as a core operational function for monitoring and verifying the quality of outputs, making the claim of exclusion completely wrong.
Point-of-Care Testing Indian Medical PG Question 6: Gene amplification is achieved through
- A. Polymerase Chain Reaction (Correct Answer)
- B. DNA strand hybridization
- C. In situ DNA hybridization
- D. Ligase chain reaction (LCR)
Point-of-Care Testing Explanation: ***Polymerase Chain Reaction***
- **PCR** is the **gold standard** molecular biology technique that generates **millions to billions of copies** of a specific DNA segment over a short period.
- It utilizes a cyclical process of **denaturation**, **annealing**, and **extension** with **thermostable DNA polymerase** to achieve exponential amplification.
- **Most widely used** method for gene amplification in research and diagnostics.
*DNA strand hybridization*
- **DNA strand hybridization** is the process where two complementary single-stranded DNA molecules bind together to form a **double-stranded molecule**.
- This process is fundamental to many molecular techniques but does not, in itself, achieve **amplification**; rather, it is a **binding event**.
*In situ DNA hybridization*
- **In situ hybridization** is a technique that localizes and detects specific **nucleic acid sequences** (DNA or RNA) within cells or tissues directly on a slide.
- While it uses **hybridization**, its primary purpose is **detection and localization**, not the **amplification** of DNA sequences.
*Ligase chain reaction (LCR)*
- **LCR** is a molecular technique that does amplify DNA sequences exponentially using **DNA ligase** to join adjacent oligonucleotide probes.
- However, it is **less commonly used** than PCR, has more **stringent requirements** (requires knowledge of both strands), and is primarily used for detecting **known point mutations** rather than general gene amplification.
- **PCR remains the standard** technique when the question refers to gene amplification without additional qualifiers.
Point-of-Care Testing Indian Medical PG Question 7: In the context of medical screening, how does a series testing approach affect the net sensitivity and net specificity of the screening methods?
- A. Net sensitivity is decreased and net specificity is increased (Correct Answer)
- B. Net sensitivity and net specificity are both increased
- C. Net sensitivity is increased and net specificity is decreased
- D. Net sensitivity remains the same and net specificity is increased
Point-of-Care Testing Explanation: ***Net sensitivity is decreased and net specificity is increased***
- In **series (sequential) testing**, a positive diagnosis requires **ALL tests to be positive**. If any single test is negative, the overall result is negative.
- **Net sensitivity DECREASES** because a person with disease must test positive on all tests in the series. If they test negative on even one test, they become a false negative. Formula: Sensitivity_net = Sensitivity₁ × Sensitivity₂ (always lower than individual sensitivities)
- **Net specificity INCREASES** because a person without disease needs only ONE negative test result to be correctly classified as negative. Formula: Specificity_net = 1 - [(1-Specificity₁) × (1-Specificity₂)] (always higher than individual specificities)
- **Series testing is used when high specificity is needed** (to rule IN disease, confirm diagnosis, minimize false positives)
*Net sensitivity is increased and net specificity is decreased*
- This describes **parallel (simultaneous) testing**, not series testing
- In parallel testing, a positive result on **ANY test** leads to positive diagnosis
- Parallel testing increases sensitivity (catches more true positives) but decreases specificity (more false positives)
- Parallel testing is used for screening when you don't want to miss cases
*Net sensitivity and net specificity are both increased*
- This is **mathematically impossible** in real-world testing scenarios
- Sensitivity and specificity have an inverse relationship - improving one typically decreases the other
- No testing strategy (series or parallel) can simultaneously increase both parameters above individual test values
*Net sensitivity remains the same and net specificity is increased*
- This is incorrect because series testing **always affects both** sensitivity and specificity
- The multiplicative nature of series testing means sensitivity must decrease when multiple tests are required to be positive
- You cannot maintain sensitivity while requiring agreement across multiple tests
Point-of-Care Testing Indian Medical PG Question 8: Test done for Mycobacterium tuberculosis based on CMI is
- A. GenXpert
- B. BACTEC
- C. Culture
- D. IGRA (Correct Answer)
Point-of-Care Testing Explanation: ***IGRA***
- **Interferon-gamma release assays (IGRAs)** measure the host's **cellular immune response** to *Mycobacterium tuberculosis* antigens.
- They assess the release of **interferon-gamma** by T cells sensitized to specific mycobacterial antigens, indicating CMI.
*GenXpert*
- **GeneXpert MTB/RIF** is a **molecular test** that detects *M. tuberculosis* DNA and rifampicin resistance.
- While it's a rapid diagnostic tool, it's based on **nucleic acid amplification**, not CMI.
*BACTEC*
- **BACTEC** is a **radiometric or fluorometric culture system** used for rapid detection and growth of *M. tuberculosis*.
- This method assesses bacterial viability and metabolic activity, not the host's cellular immune response.
*Culture*
- Mycobacterial **culture** involves growing *M. tuberculosis* in specific media to identify its presence.
- This is a direct method for detecting the organism, not an assessment of the host's cell-mediated immunity.
Point-of-Care Testing Indian Medical PG Question 9: Which of the following statements about nucleic acid amplification tests (NAATs) for STIs is FALSE?
- A. They can be used for test of cure after 3 weeks
- B. They can detect dead organisms after treatment
- C. They can be used for pharyngeal gonorrhea screening
- D. They are less sensitive than culture for rectal chlamydia (Correct Answer)
Point-of-Care Testing Explanation: ***They are less sensitive than culture for rectal chlamydia***
- This statement is **FALSE**. NAATs are generally **more sensitive** than culture methods for detecting *Chlamydia trachomatis* in all anatomical sites, including the rectum.
- The high sensitivity of NAATs allows for the detection of very low bacterial loads, making them the preferred diagnostic method for many STIs.
*They can be used for test of cure after 3 weeks*
- This statement is generally **true**. While a "test of cure" (TOC) is not routinely recommended for uncomplicated *Chlamydia* or *Gonorrhea* infections due to high treatment efficacy, it can be considered in specific circumstances (e.g., persistent symptoms, pregnancy, or use of alternative regimens).
- If a TOC is performed, it should ideally be done **no sooner than 3 weeks post-treatment** to minimize potential false positives from detecting residual nucleic acids from dead organisms.
*They can detect dead organisms after treatment*
- This statement is **true**. NAATs detect the **nucleic acids (DNA or RNA)** of the target organism.
- These nucleic acids can persist in the body for a period even after the organism has been killed by treatment, leading to a positive NAAT result despite successful eradication of the infection.
*They can be used for pharyngeal gonorrhea screening*
- This statement is **true**. NAATs are the **recommended method** for detecting *Neisseria gonorrhoeae* in extragenital sites, including the pharynx.
- Pharyngeal gonorrhea is often **asymptomatic**, making screening of at-risk individuals important for public health.
Point-of-Care Testing Indian Medical PG Question 10: A patient was suspected of having brucellosis. A serum sample was sent for a standard agglutination test, which was initially negative but became positive after dilution of the sample. What is the most likely reason for the initial negative test?
- A. Antigen antibody complexes
- B. Postzone phenomenon
- C. Complement inactivation
- D. Prozone phenomenon (Correct Answer)
Point-of-Care Testing Explanation: ***Correct: Prozone phenomenon***
- The **prozone phenomenon** occurs when there is a very high concentration of antibodies in the patient's serum, leading to the formation of small antigen-antibody complexes that do not agglutinate or precipitate.
- Diluting the sample reduces the antibody concentration, allowing for optimal antigen-antibody lattice formation and visible agglutination.
- This is the classic explanation for a **negative test becoming positive after dilution** in brucellosis serology.
*Incorrect: Antigen antibody complexes*
- While agglutination tests rely on the formation of **antigen-antibody complexes**, the initial negative result despite a positive finding after dilution indicates a specific issue with complex *visibility* or *stability* rather than the general presence of complexes.
- This option is too general and doesn't explain why dilution would change the result from negative to positive.
*Incorrect: Postzone phenomenon*
- The **postzone phenomenon** occurs when there is an *excess of antigen* relative to antibody, leading to no visible agglutination.
- In such a case, diluting the sample (which would reduce antigen concentration or keep antibody concentration too low) would typically *not* lead to a positive result; in fact, further dilution of antibodies would worsen the outcome.
- Postzone is the opposite mechanism and would not be corrected by dilution.
*Incorrect: Complement inactivation*
- **Complement inactivation** is not directly relevant to the mechanism of agglutination tests, which primarily depend on direct antibody-antigen binding for visible clumping.
- These tests do not typically require complement activity for their primary reaction, nor are they inhibited by complement inactivation.
More Point-of-Care Testing Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
